Gene therapy biotech Locanabio will shut down by the end of this year, the startup’s CEO posted on LinkedIn Wednesday afternoon. “While we continue to believe in the potential of our RNA-targeted gene therapy platform to deliver transformative therapies, the decision was made due to the time and capital required
This content was originally published here.
